Lutetium-(177Lu)-oxodotreotideHypothyroidism

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1984卷 / 1期

关键词：

D O I：

10.1007/s40278-023-50544-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：313 / 313

相关论文

共 50 条

[21] Lutetium-(177lu)-oxodotreotideLymphocytopenia: case report
Reactions Weekly, 2023, 1987 (1) : 138 - 138
[22] Lutetium-(177lu)-oxodotreotideAnaemia: case report
Reactions Weekly, 2022, 1924 (1) : 274 - 274
[23] Lutetium-(177Lu)-oxodotreotideThrombocytopenia: case report
Reactions Weekly, 2022, 1924 (1) : 277 - 277
[24] Lutetium-(177lu)-oxodotreotideHaematotoxicity: case report
Reactions Weekly, 2019, 1757 (1) : 198 - 198
[25] Lutetium-(177Lu)-oxodotreotideThrombocytopenia: case report
Reactions Weekly, 2021, 1847 (1) : 287 - 287
[26] Lutetium-(177lu)-oxodotreotideThrombocytopenia: case report
Reactions Weekly, 2023, 1944 (1) : 345 - 345
[27] Lutetium-(177lu)-oxodotreotideHaematotoxicity: case report
Reactions Weekly, 2022, 1924 (1) : 275 - 275
[28] Lutetium-(177Lu)-oxodotreotideRenal impairment: case report
Reactions Weekly, 2024, 2022 (1) : 163 - 163
[29] Lutetium-(177Lu)-oxodotreotideLack of efficacy: case report
Reactions Weekly, 2024, 2036 (1) : 262 - 262
[30] Decitabine/lutetium-(177Lu)-oxodotreotide/temozolomideVarious toxicities
Reactions Weekly, 2024, 2002 (1) : 158 - 158

← 1 2 3 4 5 →